logo

For the Inventor, By the Inventor

Brachttal, Germany

Matthias Gerlach

This inventor holds 31 USPTO granted patents and 1 published patent application and 5 EPO patents, primarily in Signal Transduction Inhibitors. Top assignees: Gruenenthal Gmbh, Aeterna Zentaris Gmbh, Zentaris Gmbh. Active years: 2003-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Gerlach. Retrieved from https://idiyas.com/inventor/matthias-gerlach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 31 

 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 89(Granted Patents)


Company Filing History:

goldMedal18 out of 361 
 
Gruenenthal Gmbh
 patents
silverMedal10 out of 36 
 
Aeterna Zentaris Gmbh
 patents
bronzeMedal2 out of 22 
 
Zentaris Gmbh
 patents
4. 1 out of 1 
 
Ae Zentaris Gmbh
 patent
5. 1 out of 5,384 
 
Centre National De La Recherche Scientifique
 patents
6. 1 out of 4 
 
University of Montpellier I
 patents
7. 1 out of 4 
 
University of Montpellier Ii
 patents
where one patent can have more than one assignee

Years Active: 2003-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Pyridopyrazine Derivatives
Signal Transduction Pathways
Kinase Inhibitors
Ghrelin Antagonists
G-Protein Coupled Receptors
Indole Derivatives
Bioavailability Properties
Cancer Treatment
Pyrimidine Compounds
Ligands
31 patents (USPTO):Explore Patents
1. 8912189 - Pyridopyrazine derivatives and their use (2014-12-16),
2. 8791118 - Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors (2014-07-29),
3. 8604196 - Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-B]pyrazine-6-yl]thiourea (2013-12-10),
4. 8546435 - Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors (2013-10-01),
5. 8536332 - Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines (2013-09-17),
6. 8507486 - Pyridopyrazine derivatives, process of manufacturing and uses thereof (2013-08-13),
7. 8461178 - Naphthyridine derivatives and the use thereof as kinase inhibitors (2013-06-11),
8. 8394801 - Quinoxaline derivatives and their use for treating benign and malignant tumour disorders (2013-03-12),
9. 8202883 - Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases (2012-06-19),
10. 8067456 - Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs) (2011-11-29),
11. 7671074 - Sulfonylguanidine compounds and pharmaceutical uses thereof (2010-03-02),
12. 7375127 - Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) (2008-05-20),
13. 7230103 - Substituted 3,4-dihydropyrido[1,2-a]pyrimidines (2007-06-12),
14. 7226924 - Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use (2007-06-05),
15. 7211588 - N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation (2007-05-01),

Title: Matthias Gerlach - Innovative Inventor from Brachttal

Introduction: Matthias Gerlach is a renowned inventor hailing from Brachttal, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Matthias Gerlach holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials science.

Career Highlights: With a career spanning over two decades, Matthias Gerlach has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Matthias Gerlach has collaborated with top universities and multinational corporations to bring his inventions to market, showcasing his ability to work across different sectors and disciplines.

Conclusion: Matthias Gerlach's passion for innovation and his dedication to creating a better future through his inventions make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…